Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients
Clinical trial NCT00112229 · COMPLETED
Trial details
- NCT number
- NCT00112229
- Sponsor
- Centre Hospitalier Universitaire Vaudois
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2011-08-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.